Induction of Early Autophagic Process on Leishmania amazonensis by Synergistic Effect of Miltefosine and Innovative Semi-synthetic Thiosemicarbazone by Débora B. Scariot et al.
fmicb-08-00255 February 18, 2017 Time: 15:17 # 1
ORIGINAL RESEARCH




Aichi Gakuin University, Japan
Reviewed by:
Osmar Nascimento Silva,
Universidade Católica Dom Bosco,
Brazil
Elmo Eduardo Almeida Amaral,





This article was submitted to
Antimicrobials, Resistance
and Chemotherapy,
a section of the journal
Frontiers in Microbiology
Received: 08 November 2016
Accepted: 07 February 2017
Published: 21 February 2017
Citation:
Scariot DB, Britta EA, Moreira AL,
Falzirolli H, Silva CC,
Ueda-Nakamura T, Dias-Filho BP
and Nakamura CV (2017) Induction
of Early Autophagic Process on
Leishmania amazonensis by





Induction of Early Autophagic
Process on Leishmania amazonensis
by Synergistic Effect of Miltefosine
and Innovative Semi-synthetic
Thiosemicarbazone
Débora B. Scariot1, Elizandra A. Britta1, Amanda L. Moreira1, Hugo Falzirolli2,
Cleuza C. Silva2, Tânia Ueda-Nakamura1, Benedito P. Dias-Filho1 and
Celso V. Nakamura1*
1 Laboratório de Inovação Tecnológica no Desenvolvimento de Fármacos e Cosméticos, Departamento de Farmácia,
Universidade Estadual de Maringá, Maringá, Brazil, 2 Departamento de Química, Universidade Estadual de Maringá,
Maringá, Brazil
Drug combination therapy is a current trend to treat complex diseases. Many benefits
are expected from this strategy, such as cytotoxicity decrease, retardation of resistant
strains development, and activity increment. This study evaluated in vitro combination
between an innovative thiosemicarbazone molecule – BZTS with miltefosine, a drug
already consolidated in the leishmaniasis treatment, against Leishmania amazonensis.
Cytotoxicity effects were also evaluated on macrophages and erythrocytes. Synergistic
antileishmania effect and antagonist cytotoxicity were revealed from this combination
therapy. Mechanisms of action assays were performed in order to investigate the
main cell pathways induced by this treatment. Mitochondrial dysfunction generated
a significant increase of reactive oxygen and nitrogen species production, causing
severe cell injuries and promoting intense autophagy process and consequent apoptosis
cell death. However, this phenomenon was not strong enough to promote dead in
mammalian cell, providing the potential selective effect of the tested combination for the
protozoa. Thus, the results confirmed that drugs involved in distinct metabolic routes
are promising agents for drug combination therapy, promoting a synergistic effect.
Keywords: Leishmania amazonensis, drug combination, apoptosis, autophagy, synergism, miltefosine,
thiosemicarbazone
INTRODUCTION
Drug combination therapy is widely used to treat diseases resistant to conventional therapy, such as
cancer and AIDS. Currently, this strategy have been employed to avoid or delay the development of
resistant mechanism. Other benefit reached by drug association therapy is the toxicity reduction,
since lower doses of each combined drug is at least enough to obtain the same effect of drugs
singly. However, the synergistic effect should go beyond the sum of the individual effects (Chou,
2006). The traditional use of medicinal plants in the treatment of several diseases is also based on
the synergistic effect from molecules in the complex matrix, commonly found in small quantities
in plants and inactive by themselves. Synergistic effect could occur by modifying the stability,
bioavailability, solubility, and half-life of pharmacologically active substance (Bone and Mills,
2013).
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Thiosemicarbazones derivatives have been exhibited a wide
spectrum biological activity, such as antibacterial (Viñuelas-
Zahínos et al., 2011), antiprotozoa (Chellan et al., 2010; Britta
et al., 2012, 2014; Fernández et al., 2015); and antitumor (Ferraz
et al., 2011). Triapine R©, the most famous thiosemicarbazone,
have been studied in clinical trials for treat different diseases
using distinct strategies, including the combination with another
drug, according to U.S. National Institutes of Health1. Previously,
4-nitro benzaldehyde thiosemicarbazone derived from S-(-)-
limonene (BZTS) revealed promising in vitro antileishmania
activity (Britta et al., 2014).
Leishmaniasis represents a serious health public problem and
is endemic in 88 countries, mainly tropical and underdeveloped
places, where ideal climate conditions are found to sandfly
vector development. Thirty thousand deaths occur annually in
consequence of the main clinical manifestations of leishmaniasis
(World Health Organization, 2016). Pentavalent antimonials
are the first choice medicine against Leishmania spp. since
1940s. Severe side effects and increasing reports of resistant
strains make the search for new drugs and development of new
therapeutic strategies an urgent need from the clinical point of
view (Georgiev, 1997; Lira et al., 1999; Bahreini et al., 2015).
Amphotericin B and miltefosine (or hexadecyl-
phosphocholine), antifungal and antitumor originally
drugs, respectively, have been used as second line drugs to
treat leishmaniasis (Berman, 1997). Side effects, including
teratogenicity, nephrotoxicity, anemia, and cardiotoxicity,
are responsible for the difficulty to perform the complete
treatment (Dorlo et al., 2012). As consequence, resistant strains
development have been reported for all available drugs. Strategies
to improve therapies using these medicines already consolidate
at medical clinical are an interesting way to obtain advances in
the leishmaniasis treatment.
Based in these informations and considering the interesting
antileishmania profile of the BZTS, the main aim in this study
was to analyze the combination of BZTS with amphotericin B
and BZTS with miltefosine, evaluating antileishmania activity,




4-Nitrobenzaldehyde thiosemicarbazone derived from S-(-)-
limonene is an innovative substance synthesized at the State
University of Maringa, according to Britta et al. (2014).
Parasites and Macrophage Maintenance
Leishmania amazonensis MHOM/BR/75/Josefa strain was
isolated from a human case of cutaneous leishmaniasis by
Dr. Cesar A. Cuba, at University of Brasilia, Brazil (Saraiva
et al., 1983; Cuba et al., 1985). These promastigote parasites
1U.S. National Institutes of Health – Clinicaltrials.com. Available online at: https://
clinicaltrials.gov/ct2/results?term=triapine&Search=Search. Accessed March 10,
2016.
were maintained in Warren’s medium, consisting of brain
heart infusion (Gibco R©), hemin (Sigma–Aldrich R©), and folic
acid (Sigma–Aldrich R©), pH 7.2, supplemented with 10%
of fetal calf serum (FCS – Invitrogen R©) and incubated at
25◦C.
Axenic amastigote forms were obtained from L. amazonensis
promastigotes. For this, promastigote forms in phase log
of growth were cultivated in Warren’s medium, pH 7.2,
supplemented with 20% FCS and incubated at 25◦C,
during 48 h. Next, the parasites were maintained at 30◦C,
for 24 h, and at 32◦C until differentiation in amastigote
forms. Axenic amastigotes were maintained in Schneider
insect’s medium (Sigma–Aldrich R©), pH 4.6, supplemented
with 20% of FCS, at 32◦C (Ueda-Nakamura et al.,
2001).
Murine monocytic lineage macrophages J774.A1 (Rio de
Janeiro Cell Bank – BCRJ) were maintained in RPMI 1640
medium (Roswell Park memory Institute – Gibco R©), pH
7.6, supplemented with 10% of FCS and 0.4% of penicillin-
streptomycin antibiotics (Sigma-Aldrich R©), incubated at 37◦C,
5% CO2 tension and humidified atmosphere.
In vitro Activity against L. amazonensis
Suspension of 1 × 106 promastigotes/mL, in log phase of
growth, was placed in 24-wells microplate in the presence
of increasing concentrations of the BZTS, amphotericin B
(Sigma–Aldrich R©) and miltefosine (Avanti Polar Lipids Inc.),
after previous solubilization with 0.5% DMSO (Synth R©). The
same procedure was carried out with axenic amastigote forms,
using 12-wells microplate. After incubation during 72 h, at
25 and 32◦C for promastigote and axenic amastigote forms,
respectively, viable cells were counted with hemocytometer
supporting. In order to obtain the IC50, the concentration able
to inhibit 50% of the growth compared to the control, the growth
inhibition percentage was plotted in a graphic relating with the
concentration of the compounds.
Furthermore, the activity of these drugs against
L. amazonensis intracellular amastigotes was also evaluated. For
this, intraperitoneal macrophages were harvested from the males
BALB/c mice, by injection of cold phosphate-saline buffer (PBS)
plus FCS 3% inner the peritoneal cavity. After centrifugation, a
suspension of 5× 105 macrophages in RPMI was placed on glass
coverslips in 24-wells microplate and incubated during 2 h, at
37◦C and 5% CO2 atmosphere, for cellular adhesion. After this
period, the wells were washed and the macrophages were infected
with L. amazonensis promastigotes in stationary phase (5–6 days)
at a ratio of 7 parasites/1 mammalian cell, during 4 h, at 34◦C
and 5% CO2 tension and then, the tested compounds were added
during 48 h (Kaplum et al., 2016). At the end of this period, the
glass coverslips were subject to fixation with methanol during
10 min and stained with 10% Giemsa stain (GIBCO KaryoMax R©
Giemsa), for 40 min. Then, a total of 200 macrophages were
counted under light microscope, distinguishing infected cells and
amastigote parasites. Thereby, the survival index (SI = infected
cells percentage × amastigote average per infected macrophage)
was calculated considering 100% of survival for the untreated
negative control (NC). It was subsequently possible to carry
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out the comparison with samples treated for IC50 calculation
purposes.
Ethics Statement
This study was approved and performed in accordance
with the recommendations of Ethical Committee of animal
use of Universidade Estadual de Maringá (protocol n◦
2700110515/2015).
Cytotoxicity and Hemolysis Assays
Cytotoxicity effects from isolated compounds were evaluated on
J774.A1 lineage macrophages and applying colorimetric MTT
method to measure the cell viability. For this, 5 × 105 J774.A1
macrophages were seeded in 96-well microplate and incubated
for 24 h, at 37◦C and 5% CO2 to promote the multiplication to
form a monolayer of confluent cells. Increasing concentrations
of the BZTS, amphotericin B and miltefosine were added on the
mammalian cells and incubated again under the same conditions
for 48 h. In order to evaluate the cell viability from ability
of the macrophages to metabolize MTT to purple formazan
crystals, 50 µL of MTT solution (2 mg/mL – Amresco R©) was
added in each well, for 4 h, in the absence of light. DMSO was
used to solubilize formazan crystals and then the absorbance
was read in microplate reader (BIO-TEK Power Wave XS) at
570 nm (Mosmann, 1983). The construction of dose-response
curve allowed the calculation of the cytotoxicity concentration
that reduced 50% of the absorbance value when compared
to the untreated NC, represented by the CC50. Assessing the
possibility of drug-induced hemolysis, the hemolytic activity was
evaluated in vitro from defibrinated sheep blood, commercially
obtained (Laborclin; lot n◦ 51109038). Erythrocyte suspension
at 6% was prepared by centrifugation in 2,000 × g, for
10 min and placed in 96-wells with the different concentrations
of each compound. As positive control, it used Triton X
(Synth R©) surfactant. After 2 h at 37◦C, all samples were
centrifuged for 3 min, and the supernatant was harvested to
verify the hemoglobin release by the absorbance measured in
540 nm.
Drug Combination Assays
Analyzing the combination profile of BZTS with amphotericin B
and BZTS with miltefosine, the checkerboard methodology was
applied to obtain the combination index (CI), according
to Chou and Talalay (1984), reviewed for Zhao et al.
(2010). Briefly, promastigotes, axenic and intracellular
amastigotes were prepared even as previously described
(see the section In vitro Activity against L. amazonensis)
as well the macrophages and erythrocytes, according to
the section Cytotoxicity and Hemolysis Assays. Next,
decreasing concentrations of BZTS was disposed into the
first microplate row and the other drug (amphotericin B
or miltefosine) was placed into the first microplate column.
Thus, the compounds were singly evaluated in the first row
and column and the checkerboard model supported the
drug combination in the other wells. Next, the parasites
were added and, after incubation, as described above, it was
possible to determine the IC50 for the association. Finding the
behavior of each association, the CI was calculated from the
formula:
CI = (IC 50 compound A associated/IC 50 compound A alone)
+ (IC 50 compound B associated/IC 50 compound B alone).
CI values lower, equal and greater than one indicate, respectively,
synergistic, additive and antagonistic profile of association
tested, according established by Chou and Talalay (1984)
and Chou (2010). These results allowed to evaluate the most
appropriate combination, comparing the antileishmania
combination activity and the cytotoxic and hemolytic
combination profile. Thus, the tests to investigate the mechanism
of action were performed only from the most interesting
association.
Electron Microscopy
Scanning electron microscopy was carried out to analyze the
morphologic alterations on cell surface topography. Briefly,
L. amazonensis promastigote forms (1 × 106 parasites/mL) were
treated with drugs concentrations related to IC50 and IC90 of
BZTS and miltefosine, alone and in association, for comparison
(BZTS IC50: 4.16 µM; BZTS IC90: 13.87 µM; miltefosine IC50:
20.75 µM; miltefosine IC90: 86.66 µM; BZTS + miltefosine
IC50: 1.78 µM + 6.93 µM; BZTS + miltefosine IC90:
6.93 µM + 18.89 µM). After incubation for 72 h, at 25◦C, the
samples were fixed in 2.5% glutaraldehyde in 0.1 M sodium
cacodylate buffer (Electron Microscopy Sciences – EMS R©) for
24 h. It used poly-L-lysine (Electron Microscopy Sciences –
EMS R©) to promote the fixed parasites adhesion over coverslips,
which were dehydrated with increasing concentration of ethanol
(30, 40, 50, 60, 70, 80, 90, 95, 100% – Sigma–Aldrich R©). The
samples were critical-point-dried (Baltec SCD-030) in CO2 to
remove any water trace, placed on appropriate stub to coat
with gold alloy. The micrographs were obtained by analysis in
Shimadzu SS-550 scanning electron microscope (SEM).
In order to evaluate the ultrastructure changes in the treated
parasites, promastigote forms were treated and fixed according
described above. These samples were post-fixed with 1% OsO4
(Electron Microscopy Sciences – EMS R©) and 0.8% potassium
ferrocyanide (Electron Microscopy Sciences – EMS R©), in the
dark, during 60 min, at room temperature. This procedure
increases the contrast to link with lipids. The samples were
washed in 0.1 M sodium cacodylate buffer and dehydrated
in increased concentration of acetone (50, 70, 80, 90, 95,
100% – Sigma–Aldrich R©). All acetone content was replaced by
cell diffusion for EPONTM epoxy resin, gradually, and after
48 h, at 60◦C, the resin was polymerized. Nanometric cuts
(60–70 nm) were obtained on ultramicrotome (Power Tome X
RMC Products), contrasted with 5% uranyl acetate (Electron
Microscopy Sciences – EMS R©) and 2% lead citrate (Electron
Microscopy Sciences – EMS R©). Finally, the samples were analyzed
by transmission electron microscope (TEM) JEOL – JEM 1400.
Flow Cytometer Assays
All flow cytometry analysis were performed from parasites
treated with isolated miltefosine and BZTS with miltefosine
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association, using the following concentrations related to
2 × IC90: miltefosine: 173.32 µM; BZTS + miltefosine:
13.86 µM + 37.78 µM. For these studies, the treated protozoa
were incubated during 24 h, at 25◦C.
Volume Analysis of L. amazonensis Promastigote
Forms
After to treat 1 × 107 promastigote forms with 20 mM
actinomycin D (positive control – Sigma–Aldrich R©), isolated
miltefosine and BZTS with miltefosine, the samples were washed
two times with PBS 0.01 M and incubated. Cell volume was
measured on BD FACSCalibur flow cytometer and 10,000 events
were analyzed by CellQuest Pro software.
Evaluation of Cell Membrane Integrity
L. amazonensis promastigote cells were prepared according item
2.7. After incubation, the samples were washed in PBS 0.01 M
and incubated with 50 µL of propidium iodide (PI – Sigma–
Aldrich R©) 2 mg/mL at 25◦C, for 5 min. Membrane rupture
allows the entrance of PI and its binding to cell DNA. Cell
membrane integrity was measured according PI fluorescence,
on BD FACSCalibur flow cytometer, in which 10,000 events
were evaluated by CellQuest Pro software. Membrane rupture
allows the entrance of PI and its binding to cell DNA. Digitonin
saponin 40 µM (Sigma–Aldrich R©) was used as positive control
and the fluorescence measurement were compared with NC
fluorescence.
Phosphatidylserine Exposure
Promastigote suspension (1 × 107) was treated with 100 µM
CCCP (carbonyl cyanide 3-chlorophenylhydrazone – Sigma–
Aldrich R©) as positive control, isolated miltefosine and BZTS
plus miltefosine. At the end of 24 h, the samples were washed
in 0.01 M PBS and resuspended in 100 µL of binding buffer
(140 mM NaCl; 5 mM CaCl2; 10 mM HEPES-Na; pH 7.4),
followed by the addition of 5 µL of the Annexin-V-FITC
conjugated (Molecular Probes R©). After 15 min of incubation,
400 µL of binding buffer and 50 µL of PI were added.
Phosphatidylserine exhibits a binding site to connect to anionic
conjugated protein Annexin-V-FITC and its fluorescence can
be detected (Zwaal et al., 2005). Data acquisition (10,000
events) and analysis were carried out on flow cytometer BD
FACSCalibur, equipped with CellQuest Pro software. Necrosis
processes were identified by PI fluorescence in the cells while
apoptotic cells were labeled with Annexin-V-FITC, regardless of
the PI behavior.
Determination of Mitochondrial Transmembrane
Potential (19m)
Parasites were prepared according 2.7.1 item, including positive
control. After incubation, the samples were washed with 0.9%
saline and incubated for 15 min with 1 µL of rhodamine
123 solution (Rh 123 – Sigma–Aldrich R©; 5 mg/mL ethanol),
according manufacture instructions. At the same way described
above, 10,000 events were evaluated on flow cytometer BD
FACSCalibur and the data were analyzed by CellQuest Pro
software.
Fluorometric Assays
Generation of Reactive Oxygen Species (ROS)
1 × 107 promastigote/mL were treated with BZTS and
miltefosine isolated and associated, with the concentration
related to IC50 and IC90, for 24 h, at 25◦C. Parasites were counted
on Neubauer chamber in order to standardize a suspension
containing 1 × 106 parasites in PBS 0.01 M. H2DCFDA (2’,7’-
dichlorodihydrofluorescein diacetate – Sigma–Aldrich R©) 10 µM
were added in the absence of the light and incubated during
45 min. This non-fluorescence chemical dye is chemically
reduced by intracellular esterases, generating the fluorescence
compound 2’,7’- dichlorofluorescein (DFA) and indicating the
presence of ROS. Fluorescence intensity was quantified on
fluorometer Perkin-Elmer Victor X3, at λex = 488 nm and
λem = 530 (Shukla et al., 2012).
Measurement of Nitric Oxide on Promastigote Forms
and Infected Macrophages
Promastigote suspension (1 × 107 parasites/mL) and peritoneal
macrophages infected with L. amazonensis were treated with
BZTS and miltefosine, isolated and combined, in the IC50
and IC90 concentrations. Promastigote forms and infected
macrophages were incubated at 25◦C for 72 h and 34◦C
for 48 h, respectively. Infected macrophages were removed
with the aid of a cell scraper. Promastigote cells and
infected macrophage suspension were washed in 0.1 M PBS
and incubated with DAF-FM DA (4,5-diaminofluorescein
diacetate – Molecular Probes R©) 1 and 2 µM, respectively,
during 30 min, at 37◦C (Sarkar et al., 2011). Reaction
between nitric oxide (NO) and DAF–FM DA produced a
fluorescent compound – DAF-2T. Fluorescence was measured
on fluorometer Perkin-Elmer Victor X3, at λex = 495 nm and
λem = 515 nm.
Detection of Lipid Droplets Using Nile Red Dye
Parasites were prepared and standardize in accordance to item
2.8.1. Next, 5 µL of Nile Red (Sigma–Aldrich R©) 1 mg/mL
methanol were added to treated parasites and incubated
during 30 min, at dark and room temperature. Fluorescence
was measured on Perkin-Elmer Victor X3 fluorometer, at
λex = 485 nm e λem = 535 (Greenspan et al., 1985). Nile Red is a
phenoxazone dye that fluoresces intensely at yellow–gold color in
the presence of triacylglycerols, cholesterol, or cholesterol esters,
considered neutral lipids (Fowler and Greenspan, 1985).
Quantification of Autophagy Vacuoles
L. amazonensis promastigote forms were prepared and
standardize as described previously (item 2.8.1). In addition, 1µL
of Wortmannin (Sigma–Aldrich R©, 1 mg/mL), a known autophagy
inhibitor, was added in the treated samples (Blommaart et al.,
1997). After to add 10 µL of monodansylcadaverine (MDC;
Sigma–Aldrich R©) at dark, the samples were incubated for 1 h,
at 37◦C, for posteriorly analysis on Perkin-Elmer Victor X3
fluorometer, at λex = 380 nm e λem = 525 nm (Pincus et al.,
1975).
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Statistical Analysis
Numerical results were expressed by means of at least three
experiments ± standard deviation (SD). Non-parametric data
were analyzed using one-way ANOVA test and significant
difference among means were identified using Dunnett’s test.
Two-way ANOVA test were used to examine non-parametric
data with multiples variables. Intergroup statistical difference was
evaluated by Bonferroni’s test.
RESULTS
Miltefosine with BZTS Caused
Synergistic Antileishmania Activity and
Antagonistic Cytotoxic Effect In vitro
During the combination assays, isolated compounds were
evaluated in order to compare these results with those
obtained from association strategy. BZTS showed promising
antileishmania activity and presented less toxicity for J774.A1
macrophages than medicines currently used in the treatment
against leishmaniasis, such as amphotericin B and miltefosine
(Table 1).
The cytotoxicity assays revealed an inappropriate profile for
the BZTS plus amphotericin B combination, which demonstrated
additive effect for macrophages J774.A1 and synergistic effect
for erythrocytes. Anyway, the high toxicity hampered the tests
on infected macrophages. These results suggested that the
isolated drugs are at least as toxic as the combination BZTS
with amphotericin B. For this reason, BZTS with miltefosine
combination was considered more appropriated to continuation
of the study, since it presented an interesting combination profile
about cytotoxicity, with CI > 1 value, identifying antagonistic
toxic effect (Table 2).
Both tested combinations showed synergistic effect on all
evolutionary forms of L. amazonensis, represented by CI < 1
values. BZTS with amphotericin B presented a pronounced
synergism on promastigote and axenic amastigote forms.
Synergistic antiproliferative activity and antagonistic cytotoxicity
were the expected results for all combinations, since the
combined drugs need to be more effective on protozoa than on
the mammalian cell in order to consider the strategy of drugs
association advantageous for the treatment. However, only the
BZTS with miltefosine combination showed synergistic effect
about antileishmania activity and antagonist effect related to
mammalian cells cytotoxicity.
Leishmania amazonensis Promastigotes
Cells Changed after Exposed to Drugs
Isolated and Combined
BZTS with amphotericin B showed synergistic cytotoxicity
(Table 2). Thus, mechanisms of action assays were carried
out only with BZTS plus miltefosine. By SEM, it could notice
cell volume alterations and rounding of the cell body shape
(Figures 1B,C) in comparison to the untreated promastigotes
(Figure 1A). Differently, promastigotes exposed to miltefosine
revealed changes on surface cell and reduction of the flagellum
TABLE 1 | CC50 and IC50 values accompanied by the respective standard
deviations (µM ± SD) for parasites (promastigote, axenic, and intracellular
amastigote) and mammalian cells (J774.A1 macrophage and erythrocytes)
treated with isolated BZTS, miltefosine, and amphotericin B.
µM ± SD
BZTS Miltefosine Amphotericin B
CC50 Erythrocytes >500 21.45 ± 0.75 51.75 ± 4.34
J774.A1Macrophage 87.49 ± 9.07 55.12 ± 1.97 3.74 ± 0.59
IC50 Promastigote 4.16 ± 0.78 20.75 ± 0.25 0.84 ± 0.19
Axenic amastigote 8.04 ± 0.37 0.79 ± 0.48 0.43 ± 0.19
Intracellular amastigote 6.99 ± 1.22 1.82 ± 0.20 nd
Due to high cytotoxicity for macrophages, amphotericin B activity against
intracellular amastigotes was not determined (nd).
TABLE 2 | Combination profile of BZTS with miltefosine or amphotericin B
for parasites (promastigote, axenic, and intracellular amastigote) and
mammalian cells (J774.A1 macrophage and erythrocytes).
BZTS + Miltefosine BZTS + Amphotericin B
CI PROFILE CI PROFILE
Promastigote 0.73 SYNERGISTIC 0.61 SYNERGISTIC
Axenic amastigote 0.39 SYNERGISTIC 0.13 SYNERGISTIC
Intracellular amastigote 0.96 SYNERGISTIC nd nd
J774.A1 macrophage 6.28 ANTAGONIST 1.09 ADDITIVE
Erythrocytes >1.00 ANTAGONIST <0.80 SYNERGISTIC
Combination index (CI) higher, equal, and lower than one correspond to antagonist,
additive, and synergistic profile. The high cytotoxicity for macrophages did not
enable that drug combination activity using amphotericin B was determined (nd)
for intracellular amastigote forms.
length (Figures 1D,E). Alterations like cell body rounding,
flagellar changes and severe alterations on cellular surface
were observed in the samples exposed to drug combination –
BZTS+miltefosine (Figures 1F–H).
Promastigotes treated with BZTS + miltefosine showed
important ultrastructure changes by TEM in comparison to
untreated promastigotes (Figure 2A). Cells treated only with
BZTS showed mitochondrion alterations, like swelling and
concentric membranes inner mitochondria (Figures 2B,D).
Moreover, considerable lipid droplets were found in the
cytoplasm (Figure 2C) even as cytoplasmic vacuolization,
including autophagy vacuoles (Figure 2D). These findings
stimulated further studies. In general, cells exposed to miltefosine
exhibited similar changes (Figures 2E–G). Disruption of
cytoplasmic membrane was observed using miltefosine
(Figure 2H). Samples exposed to the drug combination
showed similar changes to those previously mentioned. The
main difference was related to the frequency of some changes, like
autophagy vacuoles and mitochondrial swelling (Figures 2I–L).
Synergistic Activity from BZTS Plus
Miltefosine Did Not Cause Loss of Cell
Membrane Integrity
Propidium iodide fluorescence only could be measured from
cells that have lost plasma membrane integrity enabling the
Frontiers in Microbiology | www.frontiersin.org 5 February 2017 | Volume 8 | Article 255
fmicb-08-00255 February 18, 2017 Time: 15:17 # 6
Scariot et al. Synergistic Effect: Miltefosine and Thiosemicarbazone
FIGURE 1 | Scanning electron microscopy (SEM) of L. amazonensis promastigotes. (A) promastigotes control; (B,C) promastigotes treated with
concentrations that corresponded to the BZTS IC50 and IC90, respectively; (D,E) morphology alterations after miltefosine IC50 and IC90 treatment, respectively;
(F) drug combination, at IC50; (G,H) promastigote treated with IC90 of drug combination. Scale bar = 1 µm.
internalization of the specific label. PI fluorescence increased
in 81.18% of promastigotes treated with miltefosine. By
the other hand, the synergistic activity was not able to
interfere on cell membrane integrity, represented by 19.49% of
fluorescence. Digitonin, a natural surfactant used as positive
control by promote cell permeabilization, exhibited 99.15% of PI
fluorescence (Figure 3).
Synergistic Activity from BZTS Plus
Miltefosine Caused Promastigote Cells
Volume Reduction and Early Exposition
of Phosphatidylserine
The results revealed decrease of cell volume after exposition to
drug combination (Figure 4). BZTS plus miltefosine promoted
volume decrease in 36.76% of the counted cells and 10.45% of
promastigotes treated with isolated miltefosine presented volume
reduction when compared to untreated parasites. Actinomycin D,
a known apoptosis stimulator, used as positive control, causing
51.95% of cell volume reduced.
Parasites subjected to the action of the BZTS plus miltefosine
demonstrated increase exposure of phosphatidylserine, as
evidenced by the Annexin-V-FITC label in 23.43% of counted
cells and 19.18% of the cells were considered in late apoptotic
process due to present PI fluorescence. Protozoa treated with
miltefosine singly resulted in 93.98% of fluorescence, indicating
that most of these parasites started the late apoptotic process
(Figure 5). Late apoptosis was also detected in 39.98% of the cells
exposed to 100 µM CCCP, used in this assay as positive control.
In the same sample, 5.25% of the cells showed only Annexin-V
fluorescence.
Drug Combination Altered Significantly
the Mitochondrial Profile
Rh 123 is able to accumulate inside normal polarized
mitochondrion membrane, avoiding the label escape. All treated
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FIGURE 2 | Micrographs obtained by transmission electron microscopy (TEM) showed (A) L. amazonensis promastigote forms with normal ultrastructure;
(B) treated with BZTS IC50; (C,D) treated with BZTS IC90; (E,F) IC50 miltefosine treatment; (G,H) IC90 miltefosine treatment; (I,J) association between BZTS and
miltefosine at the IC50; and (K,L) the IC90. Asterisks indicate lipid droplets on the cytoplasm; white head arrow points plasmic vacuoles; black arrows show inner
mitochondrion membrane. At the micrograph (H), the arrow emphasizes a rupture site of the plasmic membrane. (n) nucleus; (k) kinetoplast; (m) mitochondria, (f)
flagellum, (er) endoplasmic reticulum; (Gc) Golgi complex, (fp) flagelar pocket. Scale bar = 1 µm.
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FIGURE 3 | L. amazonensis promastigotes stained with stained propidium iodide. (A) untreated control; (B) treated with 40 µM digitonin; (C,D) treated with
miltefosine BZTS plus miltefosine. PI-positive cells (%) is shown in the upper quadrants.
promastigotes samples demonstrated important mitochondrial
changes, according flow cytometer analysis using Rh 123 and
the alterations visualized on TEM. Rh 123 fluorescence decrease
indicates mitochondrial membrane depolarization and label
release. Rh 123 fluorescence intensity had a strong decrease in
miltefosine-treated samples and also it was observed in parasites
treated with drug combination (Figure 6).
Additional tests were carried out to confirm the mitochondrial
changes from drug combination-treated promastigote. Data on
Figure 7 express the continuous production of reactive oxygen
species (ROS) during aerobic metabolism, showing significant
increase ROS development in the BZTS + miltefosine IC90
sample.
Nitric oxide is also a highly reactive molecule and
collaborates for the cellular oxidative stress development.
Thus, fluorescent molecule DAF-2T was used to quantifying
the NO production in promastigote and infected and non-
infected macrophages. For promastigote forms, none change
was observed after all treatments (Figure 8). Conforming
expected, the NO production after contact with drug
combination was relevant only for infected macrophage.
Non-infected macrophages were stimulated by all treatments.
After infection, it was possible to verify the NO production
increased from low concentration of miltefosine. Isolated BZTS
and drug combination presented this behavior only in higher
concentrations.
Synergistic Effect Increased the
Development of Lipid Droplets and
Autophagic Vacuole
Nile Red is a fluorescent dye and it has high affinity to lipids. If it
is solubilized on intermediary polarity lipids (phospholipids), this
dye presents red color. Or, if it is solubilized on organics solvents
or neutral lipids, as triacylglycerol, its color is gold yellow (Fowler
and Greenspan, 1985). These slight differences could be analyzed
on fluorometer. Therefore, Nile Red was chosen to evaluate lipid
droplets on promastigote cytoplasm to confirm the alterations
visualized on TEM. All treated samples demonstrated the lipid
droplets increase (Figure 9). However, only BZTS IC50, BZTS
IC90, miltefosine IC90 and association IC90 showed statistical
significance related to NC.
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FIGURE 4 | Changes on promastigote volume analyzed by flow cytometer. (A) Gray area corresponds to untreated L. amazonensis parasites;
(B) actinomycin D treatment; (C,D) miltefosine and BZTS plus miltefosine treatment, respectively, at 173.32 µM and 13.86 µM + 37.78 µM. FSC-H was considered
a function of cell size.
Monodansylcadaverine was the label chosen to detect
autophagy vacuoles after treatment with drugs alone and
in association using a quantitative method. All samples
treated with IC90 exhibited MDC fluorescence increment.
In relation to MDC fluorescence from samples treated
with the compounds and wortmannin, there was not
statistically significant differences compared to NC or
untreated parasites, suggesting that MDC was really specific
to marker autophagy vacuoles generated by drugs activity
(Figure 10).
DISCUSSION
Leishmaniasis is a spectrum of diseases caused by over than 20
species of Leishmania genus. Distinct therapeutic regimens using
the same medicines – the pentavalent antimonials – are available
to treat different leishmaniasis subtype. However, alterations on
therapeutic regimen using a single medicine are not enough
to avoid the development of resistant strains (World Health
Organization, 2010).
Drug combination is an interesting and current strategy
to treat diseases, which present resistance to available drugs,
such as cancer and infectious diseases, including AIDS and
leishmaniasis (Cullinan et al., 1994; Li et al., 2016; Trinconi
et al., 2016). According to Chou (2006), different drugs acting
in multiple targets or in different pathways against a single
target may be more efficient to treat diseases for several reasons:
drug combination increases the efficacy using lower dosage,
what suggests loss of toxicity and side effects; the actuation of
many targets or cell pathways slows up the resistant strains
development by hinder the selection of resistant individuals to
multiple mechanisms. Accordingly, these results showed that
BZTS has important synergistic activity against L. amazonensis
when combined with miltefosine or amphotericin B, both used to
treat all leishmaniasis subtypes.
Drugs highly toxic and active against several infectious
agents trend to show low selectivity. For this reason, wide
biological activity spectrum in vitro from miltefosine and
amphotericin B could be related to their cytotoxicity. Indeed,
these isolated drugs showed this toxicity. Amphotericin B
associated with BZTS kept a strong cytotoxicity on J774.A1
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FIGURE 5 | L. amazonensis phosphatidylserine exposure after 24 h of treatment. (A) Untreated promastigote; (B) treated with 100 µM CCCP; (C,D) treated
with miltefosine (173.32 µM) and drug combination (BZTS: 13.86 µM; miltefosine: 37.78 µM), respectively. Annexin-V-FITC positive cells (%) are shown in lower and
upper right quadrants.
macrophages and erythrocytes. Intense cytotoxic effects of this
combination did not allow the antileishmania activity evaluation
on intracellular amastigote forms. Miltefosine associated
with BZTS revealed promising synergistic antileishmania
activity and antagonist cytotoxicity profile on macrophages
and erythrocytes, suggesting that antileishmania activity from
miltefosine associated with BZTS is not related to toxic effects on
mammalian cells.
Oral treatment employing miltefosine or amphotericin B
by intravenous (IV) via may cause hemolytic anemia as side
effect (Cybulska et al., 1984; Queiroz et al., 2004). Intense
hemolysis is the reason for miltefosine be not administrated
by IV route (Zhukova et al., 2010). Miltefosine is an
antineoplastic medicine that acts on kinase B protein, an
important enzyme related to cell division and is responsible to
cause erythrocytes lysis.’ The present results allow to conclude
that miltefosine combined with BZTS softened cytotoxic and
hemolytic effects concomitantly to increase antileishmania
activity, characterizing the ideal for the drug association and
confirm the advantages previously described by Chou (2006).
Many researchers explore the possibility to combine miltefosine
with other drugs, mainly interested in its proven antileishmania
effect by oral route and in its still questionable safety in human’s
treatment (de Morais-Teixeira et al., 2015; Trinconi et al.,
2016).
Mechanism of action assays were carried out in order to
compare the effects of isolated and combined drugs, making
possible the investigation of cell death pathway in both cases.
In all analysis in this study carried out by flow cytometry, the
samples were treated with high doses (see Flow Cytometer Assays
section), during only 24 h of incubation. Negative results at
these circumstances could determine, for exclusion, cell pathways
not reached by tested compounds. Considering this argument,
it is possible to suggest the maintenance of plasma membrane
integrity for drug combination treatment. Membrane rupture,
swelling intracellular organelles and cell volume increase are
remarkable on necrosis process (Trump et al., 1965; Laster et al.,
1988). Necrosis process is not the main death mechanism for
tested treatments, although occurs at the end of the cellular death.
However, it seems that the treatment with high concentrations of
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FIGURE 6 | Mitochondrial potential changes on L. amazonensis after 24 h of treatment. (A) Untreated promastigote forms; (B) treated with 8 µM CCCP;
(C) treated with 173.32 µM of isolated miltefosine and (D) treated with 13.86 µM of BZTS plus 37.78 µM of miltefosine. Mitochondrial membrane depolarization
cells (%) are represented at upper and lower left quadrants.
miltefosine caused a cellular collapse, since alterations related to
all death pathways were found out, what precluded the resolution
of only one mechanism.
Phosphatidylserine externalization on cell surface works
like a signal for phagocytes to engulf the cells and eliminate
them (Segawa and Nagata, 2015). Tested drug combination
and isolated BZTS presented apoptosis features in high
concentration, more specifically, phosphatidylserine exposure
labeled with Annexin-V-FITC. Although typical ultrastructure
features of apoptosis process, like plasma membrane blebbing,
chromatin condensation and formation of apoptotic bodies,
were not figured out (Kerr et al., 1972), apoptosis process could
not be discarded completely, mainly in drug combination,
which showed positive results only Annexin-V-FITC in
majority. It is evident that miltefosine induces apoptosis
pathway conforming scientific literature (Dorlo et al.,
2012), but the wide loss of integrity membrane resulting
from treatment with high concentrations could be allowed
the bind between Annexin-V and phosphatidylserine not
externalized. Thus, it seems secure that high dosages
even during short period are interesting to accept negative
results.
Cell volume reduction observed by SEM analysis from
all samples could be endorsed by flow cytometer assays for
miltefosine and drug combination. Britta et al. (2014) were
also reported cell volume decrease, plasma membrane integrity
and positive results for Annexin-V-FITC after BZTS treatment.
Apoptosis was considered the main pathway of parasites death.
Transmission electron microscope micrographs displayed
several alterations after IC50 and IC90 treatment during 72 h. For
the purpose of quantify these alterations, fluorometry techniques
were used, conforming described at 2.8.1 item. Positive results
obtained from application of lower concentration than used for
flow cytometry studies, allow more confidence to propose the
main cell pathways attacked.
A significant increase of autophagic vacuoles was noticed
at least one tested concentration of each treatment. This short
period of incubation is appropriated to study wortmannin
Frontiers in Microbiology | www.frontiersin.org 11 February 2017 | Volume 8 | Article 255
fmicb-08-00255 February 18, 2017 Time: 15:17 # 12
Scariot et al. Synergistic Effect: Miltefosine and Thiosemicarbazone
FIGURE 7 | ROS production by untreated (NC, negative control)
L. amazonensis promastigote forms and treated with BZTS and
miltefosine isolated and combined (DC, drug combination). Detection
was carried out by intensity fluorescence generated by oxidation of
H2DCF-DA molecule and measured on Victor X3 (Perkin-Elmer) fluorometer.
At least three independent experiments were performed. ∗∗∗P ≤ 0.001,
significant difference from NC group.
effects, a known autophagy vacuoles inhibitor, whose stability
is questionable after 20 h in culture medium (Holleran
et al., 2003). Wortmannin acts on PI3k protein, which plays
essential role to regulate the autophagosome maturation for
promote the interaction with early and late endosomes and
lysosomes (Gorvel et al., 1991; Bucci et al., 1992). MDC
stain was able to consolidate the BZTS autophagy induction
proposed by Britta et al. (2014). Conforming to expect,
parasites treated with the tested drugs and wortmannin
had lost of MDC fluorescence, suggesting that autophagic
vacuoles formation was really related to drug treatment
and not related to lysosomes, emphasizing the autophagic
process.
Mitochondrial damages hypothesis on kinetoplastids
protozoa is interesting of the selectivity point of view. This
organelle is very peculiar at this protozoa family and the
mitochondrial differences between protozoa and mammalian
cells could be affect of distinct ways by the active compounds,
checking out important specificity (Inacio et al., 2012). The
results revealed mitochondrial dysfunction from treatment
with drug combination by TEM analysis, mitochondrial
membrane depolarization by Rho-123 and increase of ROS
production by H2DCFDA label. Britta et al. (2014) observed
mitochondrion changes only after BZTS treatment in high doses.
Oxidative stress in low concentrations for drug combination
and isolated miltefosine are also observed, fact that seems
be decisive for the cell death. Positive results from drug
combination suggest that the presence of miltefosine, even in
low concentrations, enabled the BZTS antileishmania activity at
shorter period.
Figarella et al. (2015) observed mitochondrial abnormalities
using the same principles used in this study, with similar
techniques. Ergosterone-coupled triazol molecules caused
an increase of ROS production, leading to DNA damage,
augmentation of autophagy and phosphatidylserine
exposure, conforming reported by scientific literature for
Trypanosomatidae family members (Figarella et al., 2006,
Chowdhury et al., 2014). Jaeger and Flohé (2006) concluded that
intracellular antioxidant defense of Leishmania spp. is totally
dependent of trypanothione system, because these protozoa not
present catalase and selenium-dependent glutathione peroxidase
enzymes. Thus, increased oxidative stress for this protozoa is an
FIGURE 8 | Measure of nitric oxide production from promastigotes, macrophages infected with amastigotes and uninfected macrophages. Cells were
untreated (NC, negative control) and treated with BZTS and miltefosine alone and in combination (DC, drug combination). Intensity fluorescence emitted from
DAF-2T was quantifying by Victor X3 (Perkin-Elmer) fluorometer. At least three independent experiments were analyzed. ∗P ≤ 0.05, significant difference from
infected NC group.
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FIGURE 9 | Lipid droplets detection on L. amazonensis promastigotes
untreated (NC) and treated with isolated and combined (DC) BZTS and
miltefosine. Nile red fluorescence was measured on Victor X3 (Perkin-Elmer)
fluorometer and at least three independent experiments were performed.
∗P ≤ 0.05 and ∗∗∗P ≤ 0.001, significant difference from NC group.
interesting pathway to be attacked, since mammalian cells seems
to have intracellular antioxidant defense system more complex
(Jaeger and Flohé, 2006).
The production of reactive nitric species, represented by NO,
peroxynitrite and nitrite dioxide radical, was also evaluated due to
their important role on nitro-oxidative cell stress (Wiseman and
Halliwell, 1996). These molecules are responsible for severe cell
damages, such as DNA alterations and modulation of the genes
action related to cell proliferation, differentiation and apoptosis
(Dizdaroglu and Jaruga, 2012). For these reasons, the quantifying
of NO was analyzed in promastigotes, firstly. Conforming the
expected, there was not changes at NO level for this axenic form
in all tested treatment.
By the inducible NO synthase (iNOS), NO plays really
important role for defense cells, especially against intracellular
parasites (Fang, 2004). NO is produced in macrophage cytoplasm
and can across the cell membranes to reach parasitophorous
vacuoles spread for cytoplasm or even diffuse outside the cell
(Bogdan, 2001). Leishmania spp. is an intracellular parasite
and developed, during the evolution, mechanism to evade of
immune response and survival inside the host-cells. Leishmania
intracellular amastigotes subverted the host-cell homeostasis,
secreting anti-inflammatory cytokines, avoiding the production
of iNOS/NO by macrophages and promoting the internalization
of protozoa by recognition of phosphatidylserine molecules on
the surface of the parasite plasma membrane (Olivier et al., 2005).
Moreover, infected macrophages are unable to produce others
pro-inflammatory cytokines necessary for the development of
an effective immune response, according in vitro studies (Matte
et al., 2001). BZTS and miltefosine, alone or in combination,
induced the NO production in non-infected macrophages. After
infection, there was a significant decrease of NO production,
but BZTS alone and combined with miltefosine were effective
to produce NO in the higher tested concentrations. The analysis
FIGURE 10 | Autophagic vacuoles quantification by
monodansylcadaverine fluorescence measure. L. amazonensis
promastigotes were untreated (NC, negative control) or treated with isolated
and combined (DC, drug combination) BZTS and miltefosine. Samples were
also treated with Wortmannin, an autophagy inhibitor. Intensity fluorescence
was measured on Victor X3 (Perkin-Elmer) fluorometer. ∗P ≤ 0.05,
∗∗P ≤ 0.01, and ∗∗∗P ≤ 0.001, significant difference from NC group.
also showed that NO production of miltefosine is not dose-
dependent. Ponte et al. (2012) suggested that the inhibition
of L-arginine oxidation, the NO precursor, could decrease NO
production after contact with high miltefosine dosage.
It is still possible to suggest that mitochondrial dysfunction
profile could lead to lipid metabolism changes besides supposed
alteration on biosynthesis of lipid precursors generated by the
treatments. Lipid bodies are dynamic intracellular organelles
composed of a neutral lipid core surrounded by phospholipids
and associated proteins that interact with other cell components
(Murphy, 2001). These structures formation is a common process
in the cell and their role is to work like fatty acid energy
sources and cholesterol depots. Excessive accumulation in the
cell cytoplasm is characteristic of pathological degenerative
diseases in mammalian cells, like type 2 diabetes, Parkinson’s
disease, some cancers and Alzheimer’s (Martin and Parton,
2005). Previous studies demonstrated increase of accumulation
of lipid bodies in cytoplasm after squalene synthase inhibitor
treatment and consequent inhibition of the sterol production
on L. amazonensis (Rodrigues et al., 2008). Lipid metabolism
perturbations due to inhibition of some pathway or oxidation
by ROS could deposit abnormal intermediates, maybe leading to
loss of the lipid original function for cell metabolism (Younce and
Kolattukudy, 2012; Kathuria et al., 2014).
Autophagy is a normal cell process. It could be considered
an evolutionary mechanism and an ancient adaptive function
developed from eukaryotic cells. Autophagy is hazardous for
collaborating to cell death, but has a beneficial role, since
intend the recycling of damaged cellular components. Autophagy
starts with the autophagosome formation delimited by double
segregating membrane (Codogno and Meijer, 2005). Type-I
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programmed cell death, or autophagy, and apoptosis or type-
I programmed cell death are different but related processes.
In general, autophagy may be a pathway repair against toxic
compounds. If cell injuries were very severe, it will occur
the failure of this mechanism and consequent apoptotic cell
death. In this point is understandable the several features
shared between the processes, like cell volume shrinkage
and mitochondrial membrane permeability. Present results
may suggest that the combination therapy of drugs, which
act in both pathways – autophagy and apoptosis – like
BZTS and miltefosine, respectively, can generate a synergistic
effect. Cell death by autophagy process have been studied
from others thiosemicarbazone molecules against cancer
cell lines and Trypanosoma cruzi (Soares et al., 2012;
Carvalho et al., 2014). At kinetoplastids protozoa, autophagy
seems have its great role during different life-cycle stages,
according environment alterations. This allows to suggest
that autophagy is a pathway that may be explored like a
target against trypanosomatids infection (Brennand et al.,
2012).
Reactive oxygen species and RNS are responsible for the nitro-
oxidative stress and collaborate for both pathways. However, NO
could modulate the autophagy on mammalian cells, working like
a signal for the cell restore the homeostasis in order to inhibit the
cell death (Filomeni et al., 2015). Thus, the NO produced by drug
combination treatment could act protecting the macrophages
cells and inducing autophagy/apoptosis death on parasites.
In summary, the association between BZTS with miltefosine
showed promising in vitro profile against L. amazonensis.
Antagonist cytotoxic effects could be the most attractive
results, since cytotoxicity is the main problem about available
leishmaniasis treatment.
Mitochondrial damage induces nitro-oxidative stress,
which may promote different responses from parasites and
macrophages after drug combination. Furthermore, low
concentrations of the two drugs were enough to obtain a
synergistic effect, what may mean that these amounts are not
able to activate the cell death process on macrophages, since that
host-cell has a stronger cell antioxidant defense system.
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